Neo Ivy Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-704
Closed -$124K 597
2022
Q2
$124K Buy
704
+696
+8,700% +$100K 0.33% 100
2022
Q1
$2K Sell
8
-2,111
-100% -$286K ﹤0.01% 465
2021
Q4
$328K Sell
2,119
-120
-5% -$20.1K 0.47% 69
2021
Q3
$380K Buy
+2,239
New +$348K 0.44% 82
2021
Q2
Sell
-897
Closed -$125K 650
2021
Q1
$125K Buy
897
+190
+27% +$30.6K 0.14% 214
2020
Q4
$124K Sell
707
-787
-53% -$147K 0.14% 229
2020
Q3
$292K Sell
1,494
-745
-33% -$125K 0.3% 125
2020
Q2
$380K Buy
2,239
+1,099
+96% +$164K 0.44% 82
2020
Q1
$132K Buy
+1,140
New +$126K 0.22% 187
2019
Q4
Sell
-2,048
Closed -$149K 417
2019
Q3
$149K Buy
+2,048
New +$150K 0.1% 216

Other funds holding SGEN

Neo Ivy Capital Management's SGEN Position: Q3 2022 in Review

Neo Ivy Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 704 shares — an estimated $124K sold.

Neo Ivy Capital Management first reported a position in SGEN in Q3 2019 and held it in 10 quarters. The position peaked at $380K in Q3 2021. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Neo Ivy Capital Management reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Neo Ivy Capital Management sold 704 Seagen Inc. Common Stock shares in Q3 2022, an estimated $124K.
  • Neo Ivy Capital Management first reported a position in Seagen Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • Neo Ivy Capital Management's Seagen Inc. Common Stock position peaked at $380K in Q3 2021.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Neo Ivy Capital Management's 13F filing for Q3 2022, filed 16 Nov 2022.